Adrian Newman-Tancredi, PhD, DSc, offers consulting in pre-clinical neuropharmacology and drug discovery for life-science companies and funding agencies. Therapeutic areas: psychopharmacology (antipsychotics, antidepressants), chronic pain, neurology (antiparkinson's disease drugs)
http://www.neuroact.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
0.9 seconds
16x16
32x32
64x64
128x128
160x160
192x192
256x256
REGATE
Susan Newman
25 rue de●●●●●●●●●ux Ricard
Ca●●es , 81100
FR
View this contact
REGATE
Susan Newman
25 rue de●●●●●●●●●ux Ricard
Ca●●es , 81100
FR
View this contact
1&1 Internet SARL
Hostmaster UNETUN
7, pla●●●●●●a Gare
Sarr●●●●ines , 57200
FR
View this contact
BUY YOUR DOMAIN
14
YEARS
1
MONTHS
10
DAYS
1 & 1 INTERNET AG
WHOIS : whois.schlund.info
REFERRED : http://1and1.com
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
1
SITE IP
217.160.0.1
LOAD TIME
0.891 sec
SCORE
6.2
NeuroAct Communication | neuroact.com Reviews
https://neuroact.com
Adrian Newman-Tancredi, PhD, DSc, offers consulting in pre-clinical neuropharmacology and drug discovery for life-science companies and funding agencies. Therapeutic areas: psychopharmacology (antipsychotics, antidepressants), chronic pain, neurology (antiparkinson's disease drugs)
neuroact.com
News
http://www.neuroact.com/news.html
Enter Name and Email. Advances its consulting assignments, scientific communication and online presence. You can keep up to date with latest news by regularly checking announcements on this page. To receive occasional Newsletters by email, enter your contact details. To view previous Newsletters click here. 26 January 2015 - Adrian gives invited lecture at Bristol University. 12 January 2015 - Neurolixis announces drug discovery collaboration with Krakow University. 24 January 2014 - Just published: revi...
NeuroAct Communication - Newsletter - September 2012
http://www.neuroact.com/news/newsletters/247-neuroact-communication-newsletter-september-2012.html
Enter Name and Email. NeuroAct Communication - Newsletter - September 2012. Adrian Newman-Tancredi PhD chaired a session at the Serotonin Club. Meeting in Montpellier, France. The symposium was entitled "From ligand functional selectivity to brain region selectivity: differential pharmacological targeting of the serotonin system.". For details of the symposium click here. 25th ECNP Congress, Vienna . Adrian will be presenting at a symposium of the 25th European College of Neuropsychopharmacology ( ECNP.
08 January 2013 - Watch Adrian's ECNP lecture on webcast
http://www.neuroact.com/news/255-08-january-2013-watch-adrians-ecnp-lecture-on-webcast.html
Enter Name and Email. 08 January 2013 - Watch Adrian's ECNP lecture on webcast. A new webcast recording is available of Adrian Newman-Tancredi's recent presentation in a symposium at the 25th Congress of the ECNP (European College of NeuroPsychopharmacology) in Vienna on Monday 15 October 2012. Adrian gave a lecture on novel drugs with increased target selectivity and entitled:. Biased agonism' at cortical post-synaptic 5-HT1A receptors for improved treatment of depressive disorders .".
Publications
http://www.neuroact.com/publications.html
Antipsychotics and D3, D4. 5-HT1B, 5-HT1D and 5-HT2. Offers expert guidance to scientific communication. Define a publication strategy: identify objectives, target audience, journals. Aid to effective presentation of pharmacological data. Experienced scientific writing and editing: research reports, posters, symposia. For more information Contact. Adrian Newman-Tancredi, PhD, DSc, . Believes that scientific communication favors creativity. Posters and conference lectures: over 160.
Executive Profile
http://www.neuroact.com/executiveprofile-adrian-newman-tancredi.html
Is a consulting service founded by Adrian Newman-Tancredi. Adrian's strategy for successful drug discovery in neuropsychiatry and neurology is based on close integration of molecular, neurochemical and behavioural pharmacology. Multi-disciplinary characterisation of NCEs. Early stage inclusion of whole-animal assays. Thorough candidate profiling before development decisions. For more information Contact. Adrian Newman-Tancredi Ph.D., D.Sc. And then co-founded Neurolixis. In 2011, a neuroscience-focused b...
TOTAL PAGES IN THIS WEBSITE
20
Adrian Newman-Tancredi
http://www.neurolixis.com/en/people/management/adrian-newman-tancredi.html
Mark A. Varney. Steven A. Johnson. Mark H.N. Corrigan. Adrian Newman-Tancredi, PhD, DSc. Co-Founder and Chief Scientific Officer. And befiradol ( NLX-112. In addition, Dr. Newman-Tancredi managed the program that led to the discovery of the serotonergic "biased agonist", F15599 ( NLX-101. And as an independent drug discovery consultant ( www.neuroact.com. Neurolixis - contact@neurolixis.com. Mark A. Varney. Steven A. Johnson. Mark H.N. Corrigan.
TOTAL LINKS TO THIS WEBSITE
1
Center for Neuroacoustic Research
www.neuroacoustic.info
This Web page parked FREE courtesy of Incipient Domains. Search for domains similar to. Is this your domain? Let's turn it into a website! Would you like to buy this. Find Your Own Domain Name. See our full line of products. Easily Build Your Professional Website. As low as $4.99/mo. Call us any time day or night .
The Center for Neuroacoustic Research
www.neuroacoustic.us
This Web page parked FREE courtesy of Incipient Domains. Search for domains similar to. Is this your domain? Let's turn it into a website! Would you like to buy this. Find Your Own Domain Name. See our full line of products. Easily Build Your Professional Website. As low as $4.99/mo. Call us any time day or night .
Hier geht es um die Tomatis-Horchtherapie
Hier geht es um die Horchtherapie nach Dr. A. Tomatis. Wem ein Horchtraining helfen kann. Was Horchtraining ist und Wie es funktioniert. Auf Welcher wissenschaftlichen Grundlage es beruht. Wo Sie kompetente Hilfe und Unterstützung finden. In unserer Infothek finden Sie:. Aktuelle Neuigkeiten, Radiobeiträge, Literaturhinweise, Interessante Presseartikel,. Einen Fernsehbericht und eine Liste weiterführender Links.
NeuroAct Communication
26 January 2015 - Adrian gives invited lecture at Bristol University. Adrian Newman-Tancredi, PhD, DSc, gave an invited lecture on Monday 19 January 2015 at the highly-recognized School of Physiology and Pharmacology of Bristol University (UK). The. Read More. 12 January 2015 - Neurolixis announces drug discovery collaboration with Krakow University. 17 October 2014 - Adrian to chair session and present at World Orphan Drug Congress. Bioscience companies, agencies and the investment community.
Neuroactief.nl:
Bij Novartis vormt maatschappelijk verantwoord ondernemerschap een integraal onderdeel van de werkwijze. Via deze website kunt u zich registreren voor internationale congressen over ontwikkelingen in de neurologie. U kunt hieronder inloggen met de inloggegevens die u van Novartis heeft ontvangen. Rsaquo; Inloggegevens kwijt? Uw toegang tot en gebruik van deze site is onderworpen aan onze disclaimer.
Neuroaction - Desafiando límites
Neurobiology of Action | Champalimaud Neuroscience Programme
We study the neurobiology of action. In health and disease. To study actions is to study the way we do things, which is different than studying how we remember stimuli, or facts and events. Some actions are innate or pre-wired (like swallowing, breathing, even grooming). Others are learned through trial and error throughout life. We currently focus on understanding the processes mediating the latter. How do we initiate and generate diverse actions (trial),. We chose to implement this integrative approach...
neuroactiv.com
neuroactiv.net at Directnic
